A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : M2e

Search Conditions:
Search Keyword : M2e
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: M2e
Appearance Frequency: 140 time(s)
Long forms: 20

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
matrix protein 2
(45 times)
Allergy and Immunology
(20 times)
HA (7 times)
Ab (3 times)
NA (3 times)
2005 Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
M2 protein
(39 times)
Allergy and Immunology
(14 times)
DIVA (3 times)
HBc (3 times)
mAb (3 times)
2002 Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.
matrix protein 2 ectodomain
(14 times)
Allergy and Immunology
(4 times)
NP (3 times)
Ad (1 time)
HA (1 time)
2009 Pandemic preparedness: toward a universal influenza vaccine.
M2 ectodomain
(12 times)
Virology
(4 times)
pH1N1 (3 times)
IFN-gamma (2 times)
Abs (1 time)
2007 Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.
matrix 2 protein
(8 times)
Allergy and Immunology
(3 times)
AdV (1 time)
HA (1 time)
M2e-HA (1 time)
2007 Characterization of immunity induced by M2e of influenza virus.
M2 extracellular
(4 times)
Virology
(2 times)
HA (2 times)
MN (2 times)
C3KO (1 time)
2015 Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
anti-M2 ectodomain
(2 times)
Veterinary Medicine
(1 time)
--- 2012 Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus.
M2 from influenza virus
(2 times)
Biochemistry
(2 times)
MAPs (2 times)
SPPS (1 time)
2010 Strategies and limitations in dendrimeric immunogen synthesis. The influenza virus M2e epitope as a case study.
M2-protein of influenza A virus
(2 times)
Allergy and Immunology
(1 time)
Ab (1 time)
CPMV (1 time)
CVPs (1 time)
2009 [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
10  matrix 2 ectodomain
(2 times)
Science
(1 time)
AIV (2 times)
DIVA (2 times)
cAbs (1 time)
2016 Avian Influenza Virus and DIVA Strategies.
11  M2 antigen
(1 time)
Veterinary Medicine
(1 time)
KLH-M2e (1 time)
LL (1 time)
2013 A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.
12  M2 ectodomain of avian influenza virus
(1 time)
Parasitology
(1 time)
EYFP (1 time)
M2e-EYFP (1 time)
2013 Development of transgenic lines of Eimeria tenella expressing M2e-enhanced yellow fluorescent protein (M2e-EYFP).
13  M2 external domain
(1 time)
Allergy and Immunology
(1 time)
--- 2009 Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.
14  M2 extracellular domain
(1 time)
Immune System Diseases
(1 time)
H3N2i (1 time)
HA VLP (1 time)
KO (1 time)
2017 Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.
15  M2 protein has a highly conserved ectodomain
(1 time)
--- 2018 Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus.
16  M2 protein of influenza virus or its ectodomain
(1 time)
Medicine
(1 time)
--- 2008 Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency.
17  made of the matrix protein 2
(1 time)
Biotechnology
(1 time)
NP (1 time)
2018 The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.
18  matrix protein 2 extracellular domain
(1 time)
Medicine
(1 time)
HA (1 time)
MVA (1 time)
NP (1 time)
2014 MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.
19  membrane matrix protein 2
(1 time)
Virology
(1 time)
IgG (1 time)
MDCK (1 time)
2017 Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.
20  mice with matrix protein 2
(1 time)
Virology
(1 time)
CTLs (1 time)
RSV (1 time)
2013 Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.